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Summary: Educational attainment (EA) is strongly influenced by social and other 6 
environmental factors, but genetic factors are also estimated to account for at least 20% of the 7 
variation across individuals1. We report the results of a genome-wide association study 8 
(GWAS) for EA that extends our earlier discovery sample1,2 of 101,069 individuals to 9 
293,723 individuals, and a replication in an independent sample of 111,349 individuals from 10 
the UK Biobank. We now identify 74 genome-wide significant loci associated with number 11 
of years of schooling completed. Single-nucleotide polymorphisms (SNPs) associated with 12 
educational attainment are disproportionately found in genomic regions regulating gene 13 
expression in the fetal brain. Candidate genes are preferentially expressed in neural tissue, 14 
especially during the prenatal period, and enriched for biological pathways involved in neural 15 
development. Our findings demonstrate that, even for a behavioral phenotype that is mostly 16 
environmentally determined, a well-powered GWAS identifies replicable associated genetic 17 
variants that suggest biologically relevant pathways. Because EA is measured in large 18 
numbers of individuals, it will continue to be useful as a proxy phenotype in efforts to 19 
characterize the genetic influences of related phenotypes, including cognition and 20 
neuropsychiatric disease. 21 
 22 
Main Text: 23 
We study educational attainment (EA), which is measured in all main analyses as the number 24 
of years of schooling completed (EduYears, N = 293,723, mean = 14.33, SD = 3.61; 25 
Supplementary Information sections 1.1-1.2). All genome-wide association studies (GWAS) 26 
were performed at the cohort level in samples restricted to individuals of European descent 27 
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whose EA was assessed at or above age 30. A uniform set of quality-control (QC) procedures 1 
was applied to the cohort-level summary statistics. In our GWAS meta-analysis of ~9.3M 2 
SNPs from the 1000 Genomes Project, we used sample-size weighting and applied a single 3 
round of genomic control at the cohort level. 4 
Our meta-analysis identified 74 approximately independent genome-wide significant loci. For 5 
each locus, we define the “lead SNP” as the SNP in the genomic region that has the smallest 6 
P-value (Supplementary Information section 1.6.1). Fig. 1 shows a Manhattan plot with the 7 
lead SNPs highlighted. This includes the three SNPs that reached genome-wide significance 8 
in the discovery stage of our previous GWAS meta-analysis of EA1. The quantile-quantile 9 
(Q-Q) plot of the meta-analysis (Extended Data Fig. 1) exhibits inflation (λGC = 1.28), as 10 
expected under polygenicity3. 11 
Extended Data Fig. 2 shows the estimated effect sizes of the lead SNPs. The estimates range 12 
from 0.014 to 0.048 standard deviations per allele (2.7 to 9.0 weeks of schooling), with 13 
incremental R2 in the range 0.01% to 0.035%.  14 
To quantify the amount of population stratification in the GWAS estimates that remains even 15 
after the stringent controls used by the cohorts (Supplementary Information section 1.4), we 16 
used LD Score regression4. The regression results indicate that ~8% of the observed inflation 17 
in the mean χ2 is due to bias rather than polygenic signal (Extended Data Fig. 3a),  suggesting 18 
that stratification effects are small in magnitude. We also found evidence for polygenic 19 
association signal in several within-family analyses, although these are not powered for 20 
individual SNP association testing (Supplementary Information section 2 and Extended Data 21 
Fig. 3b). 22 
To further test the robustness of our findings, we examined the within-sample and out-of-23 
sample   replicability   of   SNPs   reaching   genome-wide   significance   (Supplementary 24 
3 
  
Information sections 1.7-1.8). We found that SNPs identified in the previous EA meta-1 
analysis 2 
replicated in the new cohorts included here, and conversely, that SNPs reaching genome-wide 3 
significance in the new cohorts replicated in the old cohorts. For the out-of-sample replication 4 
analyses of our 74 lead SNPs, we used the interim release of the U.K. Biobank 5 (UKB) (N = 5 
111,349). As shown in Extended Data Fig. 4, 72 out of the 74 lead SNPs have a consistent 6 
sign (P = 1.47×10−19), 52 are significant at the 5% level (P = 2.68×10−50), and 7 reach 7 
genome-wide significance in the U.K. Biobank dataset (P = 1.41×10−42). For comparison, the 8 
corresponding expected numbers, assuming each SNP’s true effect size is its estimated effect 9 
adjusted for the winner’s curse, are 71.4, 40.3, and 0.6. (Supplementary Information section 10 
1.8.2). We also find out-of-sample replicability of our overall GWAS results: the genetic 11 
correlation between EduYears in our meta-analysis sample and in the UKB data is 0.95 (s.e. = 12 
0.021; Supplementary Table 1.14). 13 
It is known that EA, cognitive performance, and many neuropsychiatric phenotypes are 14 
phenotypically correlated, and several studies of twins find that the phenotypic correlations 15 
partly  reflect  genetic  overlap6–8  (Supplementary  Information  section  3.3.4).  Here, we 16 
investigate genetic correlation using our GWAS results for EduYears and published GWAS 17 
results for 14 other phenotypes, using bivariate Linkage-Disequilibrium (LD) Score 18 
regression9 (Supplementary  Information  section  3).  First, we estimated genetic correlations 19 
with EduYears. As shown in Fig. 2, based on overall summary statistics for associated 20 
variants, we find genetic covariance between increased EA and increased cognitive 21 
performance (P = 9.9×10-50), increased intracranial volume (P = 1.2×10-6), increased risk of 22 
bipolar disorder (P = 7×10-13), decreased risk of Alzheimer’s (P = 4×10-4), and lower 23 
neuroticism (P = 2.8×10-8). We also found positive, statistically significant, but very small, 24 
genetic correlations with height (P = 5.2×10-15) and risk of schizophrenia (P = 3.2×10-4). 25 
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Second, we examined whether our 74 lead SNPs are jointly associated with each phenotype 1 
(Extended Data Fig. 5 and Supplementary Information section 3.3.1). We reject the null 2 
hypothesis of no enrichment at P < 0.05 for 10 of the 14 phenotypes (all the exceptions are 3 
subcortical brain structures).  4 
Third, for each phenotype, we tested (in the published GWAS results) each of our 74 lead 5 
SNPs or proxy for association at a significance threshold of 0.05/74. We found a total of 25 6 
SNPs meeting this threshold for any of these phenotypes, but only one reaching genome-wide 7 
significance. While these results provide suggestive evidence that some of these SNPs may 8 
be associated with other phenotypes, further testing of these associations in independent 9 
cohorts is required (Supplementary Tables 3.2-3.4, Extended Data Fig. 6).  10 
To consider potential biological pathways, we first tested whether SNPs in particular regions 11 
of the genome are implicated by our GWAS results. Unlike what has been  found for other 12 
phenotypes, SNPs in regions that are DNase I hypersensitive in the fetal brain are more likely 13 
to be associated with EduYears by a factor of ~5 (95% confidence interval 2.89–7.07; 14 
Extended Data Fig. 7). Moreover, the 15% of SNPs residing in regions associated with 15 
histones marked in the central nervous system (CNS) explain 44% of the heritable variation 16 
(Extended Data Fig. 8a and Supplementary Table 4.4.2). This enrichment factor of ~3 for 17 
CNS (P = 2.48×10−16) is greater than that of any of the other nine tissue categories in this 18 
analysis. 19 
Given that our findings disproportionately implicate SNPs in regions regulating brain-specific 20 
gene expression, we examined whether genes located near EduYears-associated SNPs show 21 
elevated expression in neural tissue. We tested this hypothesis using data on mRNA transcript 22 
levels in the 37 adult tissues assayed by the Genotype-Tissue Expression Project (GTEx)10. 23 
Remarkably, the 13 GTEx tissues that are components of the CNS—and only those 13 24 
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tissues—show significantly elevated expression levels of genes near EduYears-associated 1 
SNPs (FDR < 0.05; Extended Data Fig. 8b and Supplementary Table 4.5.2). 2 
To investigate possible functions of the candidate genes from the GWAS associated loci, we 3 
examined the extent of their overlap with groups of genes (“gene sets”) whose products are 4 
known or predicted to participate in a common biological process11. We found 283 gene sets 5 
significantly enriched by the candidate genes identified in our GWAS (FDR < 0.05; 6 
Supplementary Table 4.5.1). To facilitate interpretation, we used a standard procedure11 to 7 
group the 283 gene sets into “clusters” defined by degree of gene overlap. The resulting 34 8 
clusters, shown in Fig. 3, paint a coherent picture, with many clusters corresponding to stages 9 
of neural development: the proliferation of neural progenitor cells and their specialization 10 
(the cluster npBAF complex), the migration of new neurons to the different layers of the 11 
cortex (forebrain development, abnormal cerebral cortex morphology), the projection of 12 
axons from neurons to their signaling targets (axonogenesis, signaling by Robo receptor), the 13 
sprouting of dendrites and their spines (dendrite,  dendritic  spine  organization),  and  14 
neuronal  signaling  and  synaptic  plasticity throughout  the  lifespan  (voltage-gated  15 
calcium  channel  complex,  synapse part,  synapse organization). 16 
Many of our results implicate candidate genes and biological pathways that are active during 17 
distinct stages of prenatal brain development. To directly examine how the expression levels 18 
of candidate genes identified in our GWAS vary over the course of development, we used 19 
gene expression data from the BrainSpan Developmental Transcriptome12. As shown in 20 
Extended Data Fig. 9, these candidate genes exhibit above-baseline expression in the brain 21 
throughout life but especially higher expression levels in the brain during prenatal 22 
development (1.36 times higher prenatally than postnatally, P = 6.02×10−8). 23 
A summary overview of some promising candidate genes for follow-up work is provided in 24 
Table 1.  25 
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We constructed polygenic scores13 to assess the joint predictive power afforded by the 1 
GWAS results (Supplementary Information section 5.2). Across our two holdout samples, the 2 
mean predictive power of a polygenic score constructed from all measured SNPs is 3.2% (P = 3 
1.18×10−39; Supplementary Table 5.2 and Supplementary Information section 5). 4 
Studies of genetic analyses of behavioral phenotypes have been prone to misinterpretation, 5 
such as characterizing identified associated variants as “genes for education.” Such 6 
characterization is not correct for many reasons: EA is primarily determined by 7 
environmental factors, the explanatory power of the  individual SNPs is small, the candidate 8 
genes may not be causal, and the genetic associations with EA are mediated by multiple 9 
intermediate phenotypes14. To illustrate this last point, we studied mediation of the 10 
association between the all-SNPs polygenic score and EduYears in two of our cohorts. We 11 
found that cognitive performance can statistically account for 23-42% of the association (P < 12 
0.001) and the personality trait “openness to experience” for approximately 7% (P < 0.001; 13 
Supplementary Information section 6). 14 
 It would also be a mistake to infer from our findings that the genetic effects operate 15 
independently of environmental factors. Indeed, a recent meta-analysis of twin studies found 16 
that genetic influences on EA are heterogeneous across countries and birth cohorts15. We 17 
conducted exploratory analyses in the Swedish Twin Registry to illustrate how environmental 18 
factors may amplify or dampen the impact of genetic influences (Supplementary Information 19 
section 7). We found that the predictive power of the all-SNPs polygenic score is 20 
heterogeneous by birth cohort, with smaller explanatory power in younger cohorts (Extended 21 
Data Fig. 10; see also Supplementary Information section 7.4 for discussion of the contrast 22 
between these results and findings from a seminal twin study that estimated EA heritability 23 
by birth cohort16). 24 
 25 
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Methods: All methods are described in the Supplementary Information. 1 
 2 
 3 
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Table 1 | Selected candidate genes implicated by bioinformatics analyses. Fifteen 1 
candidate genes implicated most consistently across various analyses. To assemble this list, 2 
each gene in a DEPICT-defined locus (Supplementary Information section 4.5) was assigned 3 
a score equal to the number of criteria it satisfies out of ten (see Supplementary Table 4.1 for 4 
details). The DEPICT prioritization P-value was used as the tiebreaker. “SNP”: the SNP in 5 
the gene’s locus with the lowest P-value in the EduYears meta-analysis. “Syndromic”: which, 6 
if any, of three neuropsychiatric disorders have been linked to de novo mutations in the gene 7 
(Supplementary Information section 4.6). “Top-ranking gene sets”: DEPICT reconstituted 8 
gene sets of which the gene is a top-20 member (Supplementary Table 4.5.1). The three most 9 
significant gene sets are shown if more than three are available. ID, intellectual disability; 10 
ASD, autism spectrum disorder; SCZ, schizophrenia. 11 
  12 
11 
  
 1 
Gene SNP Syndromic Score Top-ranking gene sets 
TBR1 rs4500960 ID, ASD 6 Developmental biology, decreased brain size, 
abnormal cerebral cortex morphology 
MEF2C rs7277187 ID, ASD 5 ErbB signaling pathway, abnormal sternum 
ossification, regulation of muscle cell 
differentiation 
ZSWIM6 rs61160187 – 5 Transcription factor binding, negative regulation 
of signal transduction, PI3K events in ErbB4 
signaling 
BCL11A rs2457660 ASD 5 Dendritic spine organization, abnormal 
hippocampal mossy fiber morphology, 
SWI/SNF-type complex 
CELSR3 rs11712056 SCZ 5 Dendrite morphogenesis, dendrite development, 
abnormal hippocampal mossy fiber morphology 
MAPT rs192818565 ID 5 Dendrite morphogenesis, abnormal hippocampal 
mossy fiber morphology, abnormal axon 
guidance 
SBNO1 rs7306755 SCZ 5 Protein serine/threonine phosphatase complex 
NBAS rs12987662 – 5 – 
NBEA rs9544418 SCZ 4 Developmental biology, signaling by Robo 
receptor, dendritic shaft 
SMARCA2 rs1871109 ID 4 – 
MAP4 rs11712056 ASD 4 Developmental biology, signaling by Robo 
receptor, SWI-SNF-type complex 
LINC00461 rs10061788 – 4 Decreased brain size, abnormal cerebral cortex 
morphology, abnormal hippocampal mossy fiber 
morphology 
POU3F2 rs9320913 – 4 Dendrite morphogenesis, developmental biology, 
decreased brain size 
RAD54L2 rs11712056 SCZ 4 Decreased brain size, SWI/SNF-type complex, 
nBAF complex 
PLK2 rs2964197 – 4 Negative regulation of signal transduction, PI3K 
events in ErbB4 signaling 
  2 
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Figure Legends 
Figure 1 | Manhattan plot for EduYears associations (N = 293,723). The x-axis is 
chromosomal position, and the y-axis is the significance on a –log10 scale. The black line 
shows the genome-wide significance level (5×10-8). The red x’s are the 74 approximately 
independent genome-wide significant associations (“lead SNPs”). The black dots labeled 
with rs numbers are the 3 Rietveld et al.1 SNPs. 
 
 
Figure 2 | Genetic correlations between EduYears and other traits. Results from bivariate 
Linkage-Disequilibrium (LD) Score regressions9: estimates of genetic correlation with brain 
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volume, neuropsychiatric, behavioral, and anthropometric phenotypes using published 
GWAS summary statistics. The error bars show the 95% confidence intervals. 
 
 
Figure 3 | Overview of biological annotation. 34 clusters of significantly enriched gene 
sets. Each cluster is named after one of its member gene sets. The color represents the P-
value of the member set exhibiting the most statistically significant enrichment. Overlap 
between pairs of clusters is represented by an edge. Edge width represents the Pearson 
correlation ρ between the two vectors of gene membership scores (ρ < 0.3, no edge; 0.3 ≤ ρ < 
0.5, thin edge; 0.5 ≤ ρ < 0.7, intermediate edge; ρ ≥ 0.7, thick edge), where each cluster’s 
vector is the vector for the gene set after which the cluster is named.  
 
Extended Data Figure Legends 
 
Extended Data Figure 1 | Quantile-quantile plot of the genome-wide association meta-
analysis of 64 EduYears results files. Observed and expected P-values are on a –log10 scale. 
The grey region depicts the 95% confidence interval under the null hypothesis of a uniform 
P-value distribution. The observed λGC is 1.28. (As reported in Supplementary Information 
section 1.5.4, the unweighted mean λGC is 1.02, the unweighted median is 1.01, and the range 
across cohorts is 0.95–1.15.) 
 
 
Extended Data Figure 2 | The distribution of effect sizes of the 74 lead SNPs. a, SNPs 
ordered by absolute value of the standardized effect of one more copy of the education-
increasing allele, with 95% confidence intervals. b, SNPs ordered by R2. Effects on EduYears 
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are benchmarked against the top 74 genome-wide significant hits identified in the largest 
GWAS conducted to date of height and body mass index (BMI), and the 48 associations 
reported for waist-to-hip ratio adjusted for BMI (WHR). These results are based on the 
GIANT consortium’s publicly available results for pooled analyses restricted to European-
ancestry individuals: 
https://www.broadinstitute.org/collaboration/giant/index.php/GIANT_consortium.  
 
 
Extended Data Figure 3 | Assessing the extent to which population stratification affects 
the estimates from the GWAS. a, LD Score regression plot with the summary statistics 
from the GWAS. Each point represents an LD Score quantile for a chromosome (the x and y 
coordinates of the point are the mean LD Score and the mean χ2 statistic of variants in that 
quantile). The facts that the intercept is close to one and that the χ2 statistics increase linearly 
with the LD Scores suggest that the bulk of the inflation in the χ2 statistics is due to true 
polygenic signal and not to population stratification. b, Estimates and 95% confidence 
intervals from individual-level and WF regressions of EduYears on polygenic scores, for 
scores constructed with sets of SNPs meeting different P-value thresholds. In addition to the 
analyses shown here, we conduct a sign concordance test, and we decompose the variance of 
the polygenic score. Overall, these analyses suggest that population stratification is unlikely 
to be a major concern for our 74 lead SNPs. See Supplementary Information section 3 for 
additional details. 
 
 
Extended Data Figure 4 | Replication of 74 lead SNPs in the UK Biobank data. Estimated 
effect sizes (in years of schooling) and 95% confidence intervals of the 74 lead SNPs in the 
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meta-analysis sample (N = 293,723) and the UK Biobank replication sample (N = 111,349). 
The reference allele is the allele associated with higher values of EduYears in the meta-
analysis sample. SNPs are in descending order of R2 in the meta-analysis sample. Of the 74 
lead SNPs, 72 have the anticipated sign in the replication sample, 52 replicate at the 0.05 
significance level, and 7 replicate at the 5×10−8 significance level.  
 
 
Extended Data Figure 5 | Q-Q plots for the 74 lead EduYears SNPs (or LD proxies) in 
published GWAS of other phenotypes. SNPs with concordant effects on both phenotypes 
are pink, and SNPs with discordant effects are blue. SNPs outside the gray area pass 
Bonferroni-corrected significance thresholds that correct for the total number of SNPs we 
tested (P < 0.05/74 = 6.8×10-4) and are labeled with their rs numbers. Observed and expected 
P-values are on a –log10 scale. For the sign concordance test: * P < 0.05, ** P < 0.01, and 
*** P < 0.001. 
Extended Data Figure 6 | Regional association plots for four of the ten prioritized SNPs 
for MHBA phenotypes identified using EduYears as a proxy phenotype: a, cognitive 
performance; b, hippocampus; c, intracranial volume; d, neuroticism. The four were selected 
because very few genome-wide significant SNPs have been previously reported for these 
traits. Data sources and methods are described in Supplementary Information section 3. The 
R2 values are from the hg19 / 1000 Genomes Nov 2014 EUR references samples. The figures 
were created with LocusZoom (http://csg.sph.umich.edu/locuszoom/). Mb, megabases. 
 
 
Extended Data Figure 7 | Application of fgwas to EduYears. See Supplementary 
Information section 4.2 for further details. a, The results of single-annotation models. 
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“Enrichment” refers to the factor by which the prior odds of association at an LD-defined 
region must be multiplied if the region bears the given annotation; this factor is estimated 
using an empirical Bayes method applied to all SNPs in the GWAS meta-analysis regardless 
of statistical significance. Annotations were derived from ENCODE and a number of other 
data sources. Plotted are the base-2 logarithms of the enrichments and their 95% confidence 
intervals. Multiple instances of the same annotation correspond to independent replicates of 
the same experiment. b, The results of combining multiple annotations and applying model 
selection and cross-validation. Although the maximum-likelihood estimates are plotted, 
model selection was performed with penalized likelihood. c, Reweighting of GWAS loci. 
Each point represents an LD-defined region of the genome, and shown are the regional 
posterior probabilities of association (PPAs). The x-axis give the PPA calculated from the 
GWAS summary statistics alone, whereas the y-axis gives the PPA upon reweighting on the 
basis of the annotations in b. The orange points represent genomic regions where the PPA is 
equivalent to the standard GWAS significance threshold only upon reweighting. 
Extended Data Figure 8 | Tissue-level biological annotation. a, The enrichment factor for 
a given tissue type is the ratio of variance explained by SNPs in that group to the overall 
fraction of SNPs in that group. To benchmark the estimates for EduYears, we compare the 
enrichment factors to those obtained when we use the largest GWAS conducted to date on 
body mass index, height, and waist-to-hip ratio adjusted for BMI. The estimates were 
produced with the LDSC python software, using the LD Scores and functional annotations 
introduced in Finucane et al. (2015) and the HapMap3 SNPs with MAF > 0.05. Each of the 
10 enrichment calculations for a particular cell type is performed independently, while each 
controlling for the 52 functional annotation categories in the full baseline model. The error 
bars show the 95% confidence intervals. b, We took measurements of gene expression by the 
Genotype-Tissue Expression (GTEx) Consortium and determined whether the genes 
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overlapping EduYears-associated loci are significantly overexpressed (relative to genes in 
random sets of loci matched by gene density) in each of 37 tissue types. These types are 
grouped in the panel by organ. The colored bars corresponding to tissues where there is 
significant overexpression. The y-axis is the significance on a –log10 scale. 
 
 
Extended Data Figure 9 | Gene-level biological annotation. a, The DEPICT-prioritized 
genes for EduYears measured in the BrainSpan Developmental Transcriptome data (red 
curve) are more strongly expressed in the brain prenatally rather than postnatally. The 
DEPICT-prioritized genes exhibit similar gene-expression levels across different brain 
regions (gray lines). Analyses were based on log2-transformed RNA-Seq data. Error bars 
represent 95% confidence intervals. b, For each phenotype and disorder, we calculated the 
overlap between the phenotype’s DEPICT-prioritized genes and genes believed to harbor de 
novo mutations causing the disorder. The bars correspond to odds ratios. EduYears, years of 
education; BMI, body mass index; WHR, waist-to-hip ratio adjusted for BMI. c, DEPICT-
prioritized genes in EduYears-associated loci exhibit substantial overlap with genes 
previously reported to harbor sites where mutations increase risk of intellectual disability and 
autism spectrum disorder (Supplementary Table 4.6.1). 
 
 
Extended Figure 10 | The predictive power of a polygenic score (PGS) varies in Sweden 
by birth cohort. Five-year rolling regressions of years of education on the PGS (left axis in 
all four panels), share of individuals not affected by the comprehensive school reform (a, 
right axis), and average distance to nearest junior high school (b, right axis), nearest high 
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school (c, right axis) and nearest college/university (d, right axis). The shaded area displays 
the 95% confidence intervals for the PGS effect. 
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